Amgen-partnered neuroscience startup rakes in another $112M

A year after emerging from stealth with what would ultimately be the fifth-largest fundraise among local life sciences companies in 2021, Neumora Therapeutics has raised another $112 million to propel its neuropsychiatric drugs forward.